A new antibody that can mount a double attack on the Sars-CoV-2 virus by binding to two different sites on the spike protein is starting human trials, leading to hopes of an antibody therapy that can maintain its effectiveness even against new variants of coronavirus. Image credit: Pixabay (Free Pixabay license) A virus is constantly...
by University of Southern California This transmission electron microscope image shows SARS-CoV-2 — also known as 2019-nCoV, the virus that causes COVID-19 — isolated from a patient in the US. Virus particles are shown emerging from the surface of cells cultured in the lab. The spikes on the outer edge of the virus particles give coronaviruses...
by Antonio Regalado Earlier this month a mutated variant of the coronavirus was detected in the UK, setting off alarms across Europe and causing some countries to ban travelers from Britain. But it’s still not clear that the new variant is much more easily transmitted, as some scientists have warned. Moreover, several companies with authorized...
